SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-169127
Filing Date
2015-05-04
Accepted
2015-05-04 16:34:59
Documents
15
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d896097d10q.htm 10-Q 446396
2 EX-10.1 d896097dex101.htm EX-10.1 108865
3 EX-10.2 d896097dex102.htm EX-10.2 116023
4 EX-10.3 d896097dex103.htm EX-10.3 116966
5 EX-10.4 d896097dex104.htm EX-10.4 6808
6 EX-31.1 d896097dex311.htm EX-31.1 9069
7 EX-31.2 d896097dex312.htm EX-31.2 9094
8 EX-32.1 d896097dex321.htm EX-32.1 3450
9 EX-32.2 d896097dex322.htm EX-32.2 3566
  Complete submission text file 0001193125-15-169127.txt   4160894

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT kerx-20150331.xml EX-101.INS 411956
11 XBRL TAXONOMY EXTENSION SCHEMA kerx-20150331.xsd EX-101.SCH 30911
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20150331_cal.xml EX-101.CAL 42686
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20150331_def.xml EX-101.DEF 226725
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20150331_lab.xml EX-101.LAB 334035
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20150331_pre.xml EX-101.PRE 265210
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 15828896
SIC: 2834 Pharmaceutical Preparations